Marvin MD - Mosaic Immunoengineerin Head ImmunoOncology

CPMV Stock  USD 0.61  0.39  39.00%   

Insider

Marvin MD is Head ImmunoOncology of Mosaic Immunoengineering
Age 79
Phone657-208-0890
Webhttps://www.mosaicie.com

Mosaic Immunoengineerin Management Efficiency

The company has return on total asset (ROA) of (4.2041) % which means that it has lost $4.2041 on every $100 spent on assets. This is way below average. Mosaic Immunoengineerin's management efficiency ratios could be used to measure how well Mosaic Immunoengineerin manages its routine affairs as well as how well it operates its assets and liabilities.
Mosaic Immunoengineering currently holds 735.15 K in liabilities. Mosaic Immunoengineering has a current ratio of 0.07, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Mosaic Immunoengineerin until it has trouble settling it off, either with new capital or with free cash flow. So, Mosaic Immunoengineerin's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mosaic Immunoengineering sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mosaic to invest in growth at high rates of return. When we think about Mosaic Immunoengineerin's use of debt, we should always consider it together with cash and equity.
Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. The company was founded in 2020 and is based in Novato, California. Mosaic Immunoengineerin operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people. Mosaic Immunoengineering [CPMV] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Mosaic Immunoengineering Leadership Team

Elected by the shareholders, the Mosaic Immunoengineerin's board of directors comprises two types of representatives: Mosaic Immunoengineerin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mosaic. The board's role is to monitor Mosaic Immunoengineerin's management team and ensure that shareholders' interests are well served. Mosaic Immunoengineerin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mosaic Immunoengineerin's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jay Carlson, Sr Relations
Steven King, Pres Chairman
Cyril Empig, Head Devel
Marvin MD, Head ImmunoOncology
Nicole Steinmetz, Acting Director
Paul CPA, CFO, VP
Joseph MPH, Head Operations

Mosaic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Mosaic Immunoengineerin a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Mosaic OTC Stock Analysis

When running Mosaic Immunoengineerin's price analysis, check to measure Mosaic Immunoengineerin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mosaic Immunoengineerin is operating at the current time. Most of Mosaic Immunoengineerin's value examination focuses on studying past and present price action to predict the probability of Mosaic Immunoengineerin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mosaic Immunoengineerin's price. Additionally, you may evaluate how the addition of Mosaic Immunoengineerin to your portfolios can decrease your overall portfolio volatility.